Predictors and outcome of sustained improvement in left ventricular function in dilated cardiomyopathy

Clinical Cardiology

Volumn 37, Issue 11, 2014, Pages 687-692

  Blechman, Ido ^a   Arad, Michael ^a   Nussbaum, Tamar ^a   Goldenberg, Ilan ^a   Freimark, Dov ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE DURATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREGNANCY COMPLICATION; VENTRICULAR ASSIST DEVICE; CARDIOMYOPATHY, DILATED; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; THERAPY;

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMYOPATHY, DILATED; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84913604529     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22331     Document Type: Article

References (28)

1. Pieske B. Reverse remodeling in heart failure - fact or fiction? Eur Heart J. 2004;6(suppl D):D66-D78.
2. McNamara DM, Starling RC, Cooper LT, et al; IMAC Investigators. Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study; J Am Coll Cardiol. 2011;58:1112-1118.
3. Choi JO, Kim EY, Lee GY, et al. Predictors of left ventricular reverse remodeling and subsequent outcome in nonischemic dilated cardiomyopathy. Circ J. 2013;77:462-469.
4. Arad M, Nussbaum T, Blechman I, et al. Prevalence and clinical predictors of reverse remodeling in patients with dilated cardiomyopathy. Isr Med Assoc J. 2014;16:405-411.
5. Park JS, Kim JW, Seo KW, et al. Recurrence of left ventricular dysfunction in patients with restored idiopathic dilated cardiomyopathy. Clin Cardiol. 2014;37:222-226.
6. Dickstein K, Cohen-Solal A, Filippatos G, et al; ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-2442.
7. Mestroni L, Maisch B, Mckenna WJ, et al. Guidelines for the study of familial dilated cardiomyopathies. Eur Heart J. 1999;20:93-102.
8. Surawicz B, Knilans TK. Chou's Electrocardiography in Clinical Practice. 5th ed. Philadelphia, PA: Saunders; 2001.
9. Merlo M, Pyxaras SA, Pinamonti B, et al. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol. 2011;57:1468-1476.
10. Grunig E, Benz A, Mereles D, et al. Prognostic value of serial cardiac assessment and familial screening in patients with dilated cardiomyopathy. Eur J Heart Fail. 2003;5:55-62.
11. Pasotti M, Klersy C, Pilotto A, et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol. 2008;52:1250-1260.
12. Cooper LT, Mather PJ, Alexis JD, et al; IMAC2 Investigators. Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women. J Card Fail. 2012;18:28-33.
13. Curigliano G, Cardinale D, Suter T, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines. Ann Oncol. 2012;23(suppl 7):vii155-vii66.
14. Shakir DK, Rasul KI. Chemotherapy induced cardiomyopathy: pathogenesis, monitoring and management. J Clin Med Res. 2009;1:8-12.
15. Wells QS, Lenihan DJ. Reversibility of left ventricular dysfunction resulting from chemotherapy: can this be expected? Prog Cardiovasc Dis. 2010;53:140-148.
16. Cardinale D, Colombo A, Lamantia G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55:213-220.
17. Hoshikawa E, Matsumura Y, Kubo T, et al. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and innodatabeta blockers in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2011;107:1065-1070.
18. Iida K, el Sersi M, Fujieda K, et al. Pathophysiologic significance of left ventricular hypertrophy in dilated cardiomyopathy. Clin Cardiol. 1996;19:704-708.
19. Doughty RN, Whalley GA, Gamble G, et al. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collborative Group. J Am Coll Cardiol. 1997;29:1060-1066.
20. Chan AK, Sanderson JE, Wang T, et al. Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure. J Am Coll Cardiol. 2007;50:591-596.
21. Remme WJ, Riegger G, Hildebrandt P, et al. The benefits of early combination treatment of carvedilol and ACE-inhibitors in mild heart failure and left ventricular systolic dysfunction: the Carvedilol and ACE-inhibitor Remodeling Mild Heart Failure Evaluation Trial (CARMEN). Cardiovasc Drugs Ther. 2004;18:57-66.
22. St John Sutton MG, Plappert T, Abraham WT, et al; Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107:1985-1990.
23. Hunt SA, Abraham WT, Chin MH, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154-e235.
24. Frigerio M, Roubina E. Drugs for left ventricular remodeling in heart failure. Am J Cardiol. 2005;96:10-18.
25. Goldenberg I, Moss AJ, Hall WJ, et al; Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Investigators. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation. 2006;113:2810-2817.
26. Yancy CW, Jessup M, Bozkurt B, et al; ACCF/AHATask Force Members. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:e147-e239.
27. Kini V, Soufi MK, Deo R, et al. Appropriateness of primary prevention implantable cardioverter defibrillators at time of generator replacement: are indications still met? J Am Coll Cardiol. 2014;63:2388-2394.
28. Kubanek M, Sramko M, Maluskova J, et al. Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy. J Am Coll Cardiol. 2013;61:54-63.